Theratechnologies Current ratio
¿Qué es el Current ratio de Theratechnologies?
El Current ratio de Theratechnologies Inc. es 1.05
¿Cuál es la definición de Current ratio?
El índice actual es un índice de liquidez que mide si una empresa tiene suficientes recursos para cumplir con sus obligaciones a corto plazo.
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio de compañías en Sector Health Care en NASDAQ en comparadas con Theratechnologies
¿Qué hace Theratechnologies?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Empresas con current ratio similar a Theratechnologies
- SPML Infra tiene Current ratio de 1.05
- The Interpublic of Companies tiene Current ratio de 1.05
- New Germany Fund Inc tiene Current ratio de 1.05
- Polyspin Exports tiene Current ratio de 1.05
- One Point One Solutions tiene Current ratio de 1.05
- Apex Resources tiene Current ratio de 1.05
- Theratechnologies tiene Current ratio de 1.05
- Compagnie d'Entreprises CFE SA tiene Current ratio de 1.05
- Bio-Thera Solutions tiene Current ratio de 1.05
- Binjiang Services Co tiene Current ratio de 1.05
- Canadian Imperial Bank Of Commerce tiene Current ratio de 1.05
- Morningstar Inc tiene Current ratio de 1.05
- Waitr Inc tiene Current ratio de 1.05